Pediatric anophthalmic sockets and orbital implants: outcomes with polymer-coated implants

Maria Kirzhner,Yevgeniy Shildkrot,Barrett G Haik,Ibrahim Qaddoumi,Carlos Rodriguez-Galindo,Matthew W Wilson
DOI: https://doi.org/10.1016/j.ophtha.2012.11.022
IF: 14.277
Ophthalmology
Abstract:Purpose: To compare wrapped and polymer-coated hydroxyapatite implants in children undergoing primary enucleation with no adjuvant therapies. Design: Retrospective, interventional cohort study. Participants: All children undergoing primary enucleation without adjuvant therapies between 1999 and 2009 at a tertiary pediatric cancer hospital. Methods: Review and analysis of patient records. Main outcome measures: Implant exposure, extrusion and migration, socket contracture, and formation of pyogenic granuloma. Results: Sixty consecutive patients undergoing primary enucleation with no adjuvant chemotherapy or radiation with follow-up of at least 12 months were included. Retinoblastoma was the diagnosis in 59 eyes (98.3%). Median follow-up was 3.6 years (range, 1.0-9.3 years). Two implant sizes were used: 20 mm in 47 patients (78.3%) and 18 mm in 13 patients (21.7%). Overall, 52 patients (86.7%) had an event-free recovery. Polymer-coated hydroxyapatite implants (43/60, 71.7%), when compared with wrapped ones (17/60, 28.3%), had a trend toward greater event-free recovery (odds ratio [OR], 1.6; 95% confidence interval [CI], 0.3-7.7) and lower exposure rate (OR, 2.1; 95% CI, 0.4-10.5). Conclusions: The use of polymer-coated hydroxyapatite implants is associated with favorable outcomes in the pediatric population. Despite observed complications, long-term implant retention is possible in most children. Financial disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
What problem does this paper attempt to address?